Research Papers:
MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 4060 views | HTML 4458 views | ?
Abstract
Shanliang Zhong1, Xiu Chen2, Dandan Wang2, Xiaohui Zhang1, Hongyu Shen2, Sujin Yang2, Mengmeng Lv2, Jinhai Tang2, Jianhua Zhao1
1Center of Clinical Laboratory Science, Jiangsu Cancer Hospital Affiliated to Nanjing Medical University, Nanjing 210009, China
2Department of General Surgery, Jiangsu Cancer Hospital Affiliated to Nanjing Medical University, Nanjing 210009, China
Correspondence to:
Jianhua Zhao, e-mail: [email protected], [email protected]
Keywords: microvesicles, breast, cancer, chemoresistance, microRNA
Received: December 02, 2015 Accepted: February 11, 2016 Published: February 18, 2016
ABSTRACT
Exosomes have been shown to transmit drug resistance through delivering miRNAs. We aimed to explore their roles in breast cancer. Three resistant sublines were established by exposing parental MDA-MB-231 cell line to docetaxel, epirubicin and vinorelbine, respectively. Preneoadjuvant chemotherapy biopsies and paired surgically-resected specimens embedded in paraffin from 23 breast cancer patients were collected. MiRNA expression profiles of the cell lines and their exosomes were evaluated using microarray. The result showed that most miRNAs in exosomes had a lower expression level than that in cells, however, some miRNAs expressed higher in exosomes than in cells, suggesting a number of miRNAs is concentrated in exosomes. Among the dysregulated miRNAs, 22 miRNAs were consistently up-regulated in exosomes and their cells of origin. We further found that 12 of the 22 miRNAs were significantly up-regulated after preneoadjuvant chemotherapy. Further study of the role of these 12 miRNAs in acquisition of drug resistance is needed to clarify their contribution to chemoresistance.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7481